IKang Healthcare (KANG US): Another Setback For Dissenters
In officially decided cases concerning dissentient shareholders in privatised US-listed China plays, the uplift to the takeover price versus time...
654 Views
Governance: The bottom-line on VIE
2021 has been a year of regulations for Chinese stocks. Alongside the intensified regulatory landscape, we have seen concerns of VIE risk resurfacing
441 Views
Ant Group Pre-IPO ESG Assessment: Seeing the Forest for the Trees
xxxx Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim...
881 Views
"Delisting Deceitful Chinese Companies Act" (Update): Purgatory, Subtexts, and Laughing to the Bank
Several weeks ago, I published an Insight titled "Delisting Deceitful Chinese Companies Act" Not a Slam Dunk and Has More Bark Than Bite if It...
813 Views
Disruption by Decentralization?
Blockchain is full of promise. Investment in the space totals billions of dollars. Large corporations, venture capital funds, and initial coin...
716 Views